SV Health Investors Seeks Associate for Dementia Discovery Fund
Investor - People | Jul 14, 2025 | SV Health Investors, LLC
SV Health Investors' Dementia Discovery Fund (DDF) is seeking an Associate to join its Boston investment team. This opportunity is aimed at candidates with a robust scientific background, experience in business or investing, and an entrepreneurial mindset, to help advance innovations in neurodegeneration. The DDF is the world's largest and one of the most prominent biotech venture capital funds dedicated to dementia treatment innovations, recently launching a $269 million fund named DDF-2. With offices in both London and Boston, and more than $550 million raised for its strategy, DDF harnesses global investment opportunities while working with influential partners such as major pharmaceutical companies and nonprofit organizations. The associate will be tasked with identifying potential investments, evaluating scientific opportunities, managing deal flows, and engaging with the scientific community to enrich DDF’s portfolio efforts.
Sectors
- Biotechnology
- Venture Capital
Geography
- United States – The job position for the Associate role at SV Health Investors is based in Boston, making the United States a key geography of the article.
- United Kingdom – SV Health Investors has offices in London, and many of its investment activities and partnerships are conducted through networks that include the UK.
Industry
- Biotechnology – The article focuses on SV Health Investors' Dementia Discovery Fund which invests in companies developing therapeutics for treating dementia, a crucial part of the biotechnology industry.
- Venture Capital – SV Health Investors is a venture capital firm that raises funds and invests in emerging companies, particularly in the biotech sector aimed at addressing unmet medical needs.
Financials
- $269 million – Amount raised for the latest fund, DDF-2, by the Dementia Discovery Fund.
- $550 million – Total amount raised for the Dementia Discovery Fund's investment strategy.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| SV Health Investors, LLC | Venture Capital Firm | Company | A venture capital firm with a specialty fund focusing on dementia and neurodegeneration therapeutics. |
| Dementia Discovery Fund | Investment Fund | Company | A large biotech venture capital fund investing in novel therapeutics for dementia. |
| Biogen, Bristol Myers Squibb, Eli Lilly and Co., GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and Takeda | Limited Partners | Company | Major pharmaceutical companies acting as limited partners and investors in the Dementia Discovery Fund. |
| AARP, Aegon, British Business Bank, Gates Frontier, Gradiant, UnitedHealth Group, Alzheimers Association, Alzheimers Research UK, LifeArc | Partners | Organization | Non-profit organizations and other corporations supporting the Dementia Discovery Fund. |